Suchergebnisse - "Ahmad, Syed A."

PubPharm (7)

1

Surgical Outcome Results From SWOG S1505 : A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma

enthalten in: Annals of surgery | 2020

von Ahmad, S. | Duong, M. | Sohal, D. | +9

CommentIn: Ann Surg. 2020 Sep 1;272(3):487. - PMID 32657915

2

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2020

von N'Guessan, K. | Davis, H. | Chu, Z. | +8

CommentIn: Mol Ther. 2020 Aug 5;28(8):1751-1752. - PMID 32702289

3

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

enthalten in: Annals of surgery | 2019

von Macedo, F. | Ryon, E. | Maithel, S. | +18

4

Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer : A Multi-Institutional Experience

enthalten in: Annals of surgical oncology | 2017

von Xia, B. | Ahmad, S. | Al Humaidi, A. | +11

5

Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?

enthalten in: Journal of surgical oncology | 2017

von Xia, B. | Fu, B. | Wang, J. | +14

6

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma : Southwest Oncology Group study S0202

enthalten in: Cancer chemotherapy and pharmacology | 2011

von Iqbal, S. | Rankin, C. | Lenz, H. | +6

7

A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal carcinoma

enthalten in: American journal of clinical oncology | 2006

von Lowy, A. | Firdaus, I. | Roychowdhury, D. | +9

1
[1]